Advancing Drug Discovery Assays

Available to view On Demand

The process of drug discovery is a time- and resource-consuming process. A successful drug discovery effort starts with developing effective assays for each step of the process.

Join us in this Webinar with Stephanie Harlfinger (Astrazeneca), Arnab Chatterjee (Calibr at Scripps Research), and Amit Choudhary (Broad Institute) for exciting discussions focusing on recent advances in assay development in the different steps of drug discovery. Dr. Harlfinger will give an overview of the in vitro assays available to interrogate the drug-drug interaction potential of drug molecules, Dr. Chatterjee will focus on drug-repurposing strategies for COVID-19, and Dr. Choudhary will focus on a cell-based platform developed to rapidly identify small-molecule inhibitors of CRISPR-associated nucleases.

Stephanie Harlfinger
ADME Team Lead
Oncology DMPK at Astrazeneca R&D
View Biography
Amit Choudhary
Assistant Professor of Medicine, Harvard Medical School; Renal Division, Brigham and Women’s Hospital;
Chemical Biology and Therapeutics Science, Broad Institute
View Biography
Arnab Chatterjee
Vice President Medicinal Chemistry, California Institute for Biomedical Research (Calibr),
Scripps Research Institute
View Biography
Moderator: Kusumika Mukherjee
Editor, Trends in Pharmacological Sciences

Registration Details:

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)